Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Historical Holders from Q1 2021 to Q3 2025

Symbol
CMMB on Nasdaq
Type / Class
Equity / Ordinary Shares / American Depositary Shares
Shares outstanding
384M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-13
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 3.2% $16.1M 13.2M Morgan Stanley 31 Jul 2025
OrbiMed Israel BioFund GP Limited Partnership 4.8% $1.18M 970K ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP 18 Jun 2025
SPHERA FUNDS MANAGEMENT LTD. 4.78% $963K 900K Sphera Funds Management Ltd. 31 Mar 2025

Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$4.89M 0
2025 Q2 4.23M $4.91M +$580K $1.16 14
2025 Q1 3.73M $4.07M -$472K $1.09 17
2024 Q4 4.16M $7.53M -$700K $1.81 16
2024 Q3 4.55M $7.14M +$3.02M $1.57 15
2024 Q2 2.67M $2.44M +$15.8K $0.91 15
2024 Q1 2.66M $2.07M -$36.3K $0.78 14
2023 Q4 2.81M $1.43M +$108K $0.51 16
2023 Q3 2.53M $2.26M -$524 $0.90 11
2023 Q2 2.53M $3.33M -$562K $1.32 10
2023 Q1 2.89M $4.56M -$696K $1.59 12
2022 Q4 3.31M $10.6M +$240K $3.20 13
2022 Q3 3.25M $8.09M -$130K $2.49 13
2022 Q2 3.29M $12.2M -$117K $3.70 13
2022 Q1 3.31M $15.9M -$114K $4.80 14
2021 Q4 3.29M $22.7M +$311K $6.90 14
2021 Q3 3.24M $35.9M +$733K $11.08 13
2021 Q2 3.09M $58.7M +$1.76M $19.02 11
2021 Q1 2.88M $82.6M +$82.6M $28.74 10